DIP
AZN icon

DT Investment Partners’s AstraZeneca AZN Stock Holding History

DT Investment Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.79K Buy
+20
New +$3.76K ﹤0.01% 465
2025
Q4 		– Sell
-65
Closed -$9.97K – 547
2025
Q3 		$9.97K Sell
65
-65
-50% -$9.84K ﹤0.01% 404
2025
Q2 		$18.2K Hold
130
– – ﹤0.01% 337
2025
Q1 		$19.1K Hold
130
– – ﹤0.01% 329
2024
Q4 		$17K Hold
130
– – ﹤0.01% 344
2024
Q3 		$20.3K Buy
+130
New +$21K ﹤0.01% 355

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DT Investment Partners's AZN Position: Q2 2026 in Review

DT Investment Partners opened a new position in AstraZeneca (AZN) in Q2 2026: 20 shares worth $3.79K. The stake represents ﹤0.01% of the portfolio and ranks #465 among its holdings. This is a return to the name: DT Investment Partners previously reported a position in AZN as recently as Q3 2025.

DT Investment Partners first reported a position in AZN in Q3 2024 and has held it in 6 quarters since. The position peaked at $20.3K in Q3 2024. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • DT Investment Partners held 20 shares of AstraZeneca worth $3.79K as of Q2 2026.
  • AstraZeneca was a new DT Investment Partners position in Q2 2026.
  • AstraZeneca made up ﹤0.01% of DT Investment Partners's portfolio in Q2 2026, its #465 holding.
  • DT Investment Partners first reported a position in AstraZeneca in Q3 2024 and has held it in 6 quarters since.
  • DT Investment Partners's AstraZeneca position peaked at $20.3K in Q3 2024.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on DT Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.